(Reuters) - India on Friday became the fourth country to approve a coronavirus vaccine developed by Oxford University and AstraZeneca, authorising the vaccine's rollout in coming weeks in the country with the second highest number of infections.
The following is what we know about the race to deliver vaccines to help end the coronavirus pandemic, which has killed more than 1.8 million people worldwide:
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
